Providing Exemplary Care in Any Setting

While the majority of oncology fellows are trained in large tertiary care academic cancer centers with extensive resources and subspecialty support, many will transition to community-based settings where care delivery models, access to therapies, and interdisciplinary collaboration may differ significantly. This shift can create gaps in preparedness to adapt clinical decision-making and maintain high-quality, evidence-based care across diverse practice environments.

Target Audience

This program is designed to meet the educational needs of physicians, nurses, PAs, pharmacists, and other health care professionals who manage patients with cancer.

Learning Objectives

Following this activity, participants should be able to:

  • Describe the key differences in resources, care delivery models, and interdisciplinary support between academic and community oncology practice settings.
  • Identify strategies to adapt evidence-based, guideline-concordant treatment plans to resource-constrained community oncology settings while demonstrating effective communication, care coordination, and clinical decision-making to maintain high-quality, patient-centered care.
  • Analyze the impact of healthcare system consolidation and evolving practice models on community oncology care delivery, and develop strategies to sustain access, quality, and patient-centered outcomes within changing organizational structures.
Additional information
Supporters: 

This activity is supported by educational grants from:

  • Taiho Oncology, Inc.
  • Revolution Medicines

Supported by an independent educational grant from Daiichi Sankyo.

This educational activity is supported by an independent medical education grant from GSK. 

Course summary
Available credit: 
  • 1.25 AAPA Category 1 CME credit
  • 1.25 ACPE contact hours
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 ANCC contact hours
  • 1.25 Participation
Course opens: 
06/15/2026
Course expires: 
03/01/2027
Part of: 
Recorded Presentations from the NCCN 2026 Oncology Fellows Program: New Horizons in Quality Cancer Care™

Moderator

Daniel A. Roberts, MD
Dana-Farber Cancer Institute
 
Panelists
 
Zhuoyan (Yan) Li, MD
Sandra and Malcolm Berman Cancer Institute at GBMC
 
Brock O'Neil, MD
Huntsman Cancer Institute at the University of Utah
 
NCCN Continuing Education Disclosure Policy
 
It is the policy of NCCN that all planners, faculty, moderators, authors, reviewers and anyone involved in the planning and delivery of NCCN continuing education activities are expected to disclose ALL financial relationships they have had in the past 24 months with ineligible companies. The ACCME Standards for Integrity and Independence require that individuals who refuse to provide this information will be disqualified from involvement in the planning and implementation of accredited continuing education presented by NCCN. NCCN identifies, mitigates and discloses to learners all relevant financial relationships.

In addition, all content has been reviewed to ensure education promotes safe, effective patient care and does not promote the products or services of an ineligible company. Content, including any presentation of therapeutic options, is fair, balanced, evidence-based, scientifically accurate, and free of commercial bias and marketing. 

Definitions  

Ineligible Company: An ineligible company is any entity whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. 

Relevant Financial Relationships: Financial relationships of any dollar amount occurring within the past 24 months are defined as relevant if the educational content an individual can control is related to the business lines or products of an ineligible company. There is no minimum financial threshold. We ask for disclosure of ALL financial relationships with ineligible companies, regardless of the amount and regardless of the potential relevance of each relationship to the education.

Faculty Disclaimers  

All faculty for this continuing education activity are competent in the subject matter and qualified by experience, training, and/or preparation for the tasks and methods of delivery. Faculty presentations may include discussion of off-label use. Faculty will disclose that the use in question is not currently approved by the FDA per the product labeling or marketing.

Faculty Disclosures

The faculty listed below have no relevant financial relationships with ineligible companies to disclose.

Brock O'Neil, MD
Daniel A. Roberts, MD
 
The faculty listed below has the following relevant financial relationships with ineligible companies to disclose. All of the relevant financial relationships listed for this individual have been mitigated. 
 
Zhuoyan (Yan) Li, MD
AstraZeneca Pharmaceuticals LP: Consulting Fee; Product/Speakers Bureau
Bristol Myers Squibb: Consulting Fee
Takeda Pharmaceuticals North America, Inc.: Consulting Fee
 
NCCN Staff Disclosures
 
None of the planners for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
image

In support of improving patient care, National Comprehensive Cancer Network (NCCN) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Physicians: NCCN designates this enduring material for a maximum of 1.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses: NCCN designates this educational activity for a maximum of 1.25 contact hours.

Pharmacists: NCCN designates this knowledge-based continuing education activity for 1.25 contact hours (0.125 CEUs) of continuing education credit. UAN: JA4008196-0000-26-048-H01-P

PAs: NCCN has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.25 AAPA Category 1 CME credits. Approval is valid until March 1, 2027. PAs should only claim credit commensurate with the extent of their participation.

Available Credit

  • 1.25 AAPA Category 1 CME credit
  • 1.25 ACPE contact hours
  • 1.25 AMA PRA Category 1 Credit™
  • 1.25 ANCC contact hours
  • 1.25 Participation
Please login or register to take this course.

Required Hardware/software

To complete this activity, users will need: 

  • A device with an Internet connection and sound playback capability (speakers or a headset) 
  • Adobe Reader or other PDF reader software for certificate viewing/printing